Greystone Financial Group, LLC Novo Nordisk A S Transaction History

Greystone Financial Group, LLC

  • $557 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 01, 2022
SELL
$95.88 - $117.08 $788,708 - $963,100
-8,226 Closed
0 $0
Q3 2021

Nov 03, 2021
SELL
$84.42 - $106.62 $384,786 - $485,973
-4,558 Reduced 35.65%
8,226 $790,000
Q2 2021

Aug 13, 2021
BUY
$67.66 - $84.76 $37,551 - $47,041
555 Added 4.54%
12,784 $1.07 Million
Q1 2021

May 13, 2021
BUY
$67.06 - $75.82 $820,076 - $927,202
12,229 New
12,229 $937,000

Others Institutions Holding NVO

# of Institutions
1,957
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Greystone Financial Group, LLC Portfolio

Follow Greystone Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greystone Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greystone Financial Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email